Type 1 diabetes: Drug delays onset by 2 years
A placebo-controlled, double-blind trial finds that teplizumab delays the onset of type 1 diabetes by a median of 2 years among high-risk individuals.
View original article
Author:
Health Topics, From Latest Studies to Medical News, Articles, and Editorial
.jpg)
